Close

Neovasc (NVCN) announced that Tiara Transapical system will be unable to receive European CE mark under current Medical Device Directive regulations

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. HCP
6. SPY
7. BSX
8. PI
9. NOW
10. CNMD


Go back to Neovasc (NVCN) announced that Tiara Transapical system will be unable to receive European CE mark under current Medical Device Directive regulations
(NASDAQ: NVCN) Delayed: 30.03 --0 (-0%)
Previous Close $30.03    52 Week High $5.04 
Open $30.03    52 Week Low $0.37 
Day High $30.03    P/E N/A 
Day Low $30.03    EPS $0.00 
Volume 133,995